HealthCare Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention ProductsBy Marie JonesAugust 11, 20250 – Global Leadership Solidified as Multi-Segment Commercialization Accelerates Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company,” Stock Code: 6922.HK),…
